Despite its high accuracy, CTA can come with tradeoffs including requiring radiologists to review a high number of images looking for findings that can be subtle, increasing case complexity and workloads. 

Umar Mahmood, MD, PhD, currently is chief of nuclear medicine and molecular imaging at Massachusetts General Hospital and a Harvard professor of radiology, will take on the title beginning Feb. 1. 

Dana Smetherman, MD, MPH, MBA, chief executive officer of the American College of Radiology, discusses key advocacy efforts amid a sea of policy change. 

The Class 2 recall pertains to the system's built-in shielding and collimation accessories. 

Leqembi (lecanemab) was approved by the FDA in 2023. It is an infusion drug that has been shown to reduce Alzheimer’s-related cognitive decline by up to 27%. 

Rad Partners "firmly" denied the allegations, which mirror a similar complaint from Aetna, contending it plans to "vigorously defend against these claims" in court. 

After losing a court battle with the Fortune 500 company last year, Jeffrey C. Allard, MD, and attorneys are homing in on an attorney's faulty credentials, claiming she "poisoned" the proceedings. 

Vital Imaging Diagnostic Centers recently alerted patients about the apparent cyberattack with an unauthorized party likely gaining access to private health information. 

Marcy Markes, NP, has secured representation from the Pacific Legal Foundation in an effort to overturn a state law that requires nurse practitioners to pay a physician “collaborator” if they wish to run their own practice. The lawsuit argues the regulation exists only to stifle competition.

The company describes Vivid Pioneer as its “most advanced, ultra-premium and adaptive cardiovascular ultrasound system yet.” It includes new and improved AI capabilities and a compact design that is still fully functional in tight workspaces.